Table 5 Adverse events of patients with TACE-Iodine 125 or TACE-RFA treatments after PSM
Adverse events | Grade I and II | Grade III and IV | ||||
|---|---|---|---|---|---|---|
TACE-RFA | TACE-Iodine 125 | P value | TACE-RFA | TACE-Iodine 125 | P value | |
Fatigue | 10 | 12 | 0.607 | 1 | 1 | > 0.99 |
Nausea | 8 | 8 | > 0.99 | 0 | 1 | > 0.99 |
Fever | 3 | 7 | 0.172 | 0 | 0 | > 0.99 |
Leucopenia | 0 | 6 | 0.003 | 0 | 0 | > 0.99 |
Liver pain | 25 | 24 | 0.794 | 2 | 2 | > 0.99 |
Hepatic hemorrhage | 3 | 2 | 0.642 | 1 | 0 | > 0.99 |
Increased ALT | 6 | 14 | 0.034 | 3 | 6 | 0.280 |
Pneumothorax | 2 | 4 | 0.389 | 0 | 0 | > 0.99 |